Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
Kidney Med ; 4(8): 100509, 2022 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-35991693

RESUMEN

Patients with kidney disease represent a medically complex group of patients with high medication burdens that could benefit from clinical pharmacy services as part of the interdisciplinary care team to optimize medication use. The "Advancing American Kidney Health" executive order includes new value-based reimbursement models to be tested by the Center for Medicare and Medicaid Innovation beginning January 2021 and January 2022. Advancing American Kidney Health executive order poses opportunities for the inclusion of comprehensive medication management. Following an iterative process integrating input from a diverse expert panel, published standards, clinical practice guidelines, peer review, and stakeholder feedback, our group developed practice standards for pharmacists caring for patients with kidney disease in health care settings. The standards focus on activities that are part of direct patient care and also include activities related to public health and advocacy, population health, leadership and management, and teaching, education and dissemination of knowledge. These standards are intended to be used by a variety of professionals, from pharmacists starting new practices to practice managers looking to add a pharmacist to the clinical team, to create standardization in services provided.

3.
J Viral Hepat ; 29(1): 21-25, 2022 01.
Artículo en Inglés | MEDLINE | ID: mdl-34586710

RESUMEN

In 2016, an eConsult service was developed within a safety net health system to expand access to hepatitis C (HCV) treatment in the primary care setting. The eConsult system provides individualized treatment recommendations from specially trained primary care pharmacists and primary care physicians to primary care providers with less experience in the rapidly changing treatment of HCV. Since its launch, this service has had a large impact in expanding care to a largely homeless and low-income urban population within our health system. We now aim to evaluate its efficacy in curing HCV. In this retrospective cohort study, we describe rates of sustained virologic response 12 weeks after treatment completion (SVR12) for those who received primary care-based HCV treatment through the eConsult system with those who were treated in primary care independent of an eConsult from 2017 to 2019. We found there was no significant difference in the proportion of patients who achieved SVR12 between the two groups. Overall, >90% of patients who received treatment achieved SVR12. Approximately 40% of patients treated for HCV received an eConsult, suggesting utility of the eConsult in expanding access and coordinating treatment for patients within our network.


Asunto(s)
Hepacivirus , Hepatitis C , Antivirales/uso terapéutico , Hepatitis C/tratamiento farmacológico , Humanos , Atención Primaria de Salud , Estudios Retrospectivos , Respuesta Virológica Sostenida
4.
J Am Coll Clin Pharm ; 4(8): 914-923, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-34518813

RESUMEN

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic forced healthcare systems to rethink healthcare delivery, and forced primary care pharmacists in our healthcare system to switch all visits that were previously face to face (FTF) to telehealth. METHODS: We conducted a retrospective observational cohort study to examine the association between medication related problems (MRPs) resolved in telehealth vs FTF primary care clinical pharmacist visits. The telehealth visits took place in the context of the COVID-19 pandemic, which forced health care systems to rethink care delivery. Data was collected for patient visits for 2 weeks in January before the pandemic and 2 weeks in June during the pandemic. RESULTS: There was significantly more average MRPs resolved per patient encounter in FTF visits compared with telehealth visits, particularly in patient encounters that were previously seen by the pharmacist, who were under 65 years old, identified as Black/African American, had chronic kidney disease but not on dialysis, diabetes with end organ damage, and had uncontrolled blood pressure and uncontrolled A1c. CONCLUSION: These results provide a start to establish criteria for which patients should be seen by a clinical pharmacist in person vs over the phone.

5.
J Pharm Pract ; 33(6): 790-798, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30979341

RESUMEN

While pharmacists have provided services in a multidisciplinary, primary care setting for decades, few publications have yet to evaluate providers' impressions of- these services. An anonymous 14-item survey distributed to nonresident primary care providers aimed to identify clinical pharmacist services that are most and least helpful to primary care providers, identify barriers to pharmacy services, and develop recommendations to improve pharmacy services in primary care. The most important pharmacist contribution identified by providers is medication management, whereas the least important contributions are case conference, panel management, quality improvement, and transition of care. The primary reasons for referrals to pharmacists included inadequately controlled chronic diseases, poor or questionable adherence, longer visits for more in-depth discussion, and complex regimen requiring frequent monitoring or titration. Providers favored pharmacists working in direct patient care versus indirect patient care activities. Although many providers perceived no barriers to pharmacist service access, pharmacists' presence and visibility were 2 barriers identified. Most providers preferred comprehensive to disease-specific medication management.


Asunto(s)
Farmacéuticos , Personal de Salud , Humanos , Percepción , Servicios Farmacéuticos , Atención Primaria de Salud , Rol Profesional
6.
J Am Pharm Assoc (2003) ; 53(2): 145-51, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23571621

RESUMEN

OBJECTIVES: To describe the creation of a health avatar, with the goals of providing patients with complete health information from various sources, establishing an interactive and customizable platform, empowering users to determine how the health information best fits or speaks to their personal needs, and providing perspective by comparing the health status of the individual with that of the individual's community. SUMMARY: The Internet is rapidly becoming integrated into Americans' daily lives. According to the 2007 Health Information National Trends Study, 69% of U.S. adults had access to the Internet and 23% reported using a social networking site. The impact of social media has further grown, and an estimated 50% of adults in America have a profile on social media. The potential for using cyber communities to improve health messaging is great. Several health care organizations have implemented the use of social media in a variety of ways to varying degrees of success. We propose a platform that automatically gathers information and reflects the health status of an individual back to the user. An avatar, which is a representation of a user, could be created and assigned characteristics that allow users to appreciate their health status. The health avatar platform also would allow users to compare their personal status with that of their community. The overall goal is to engage and then motivate users to improve their overall health status. CONCLUSION: Medicine must acknowledge the evolving relationships that the next generation of patients will have with technology. The health avatar is a platform that incorporates a connection with the health system through electronic medical records and connects individuals to the greater community.


Asunto(s)
Sistemas de Información en Salud , Medicina de Precisión/métodos , Salud Pública/métodos , Medios de Comunicación Sociales , Estado de Salud , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA